Entity Details

Primary name NUP88_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ99567
EntryNameNUP88_HUMAN
FullNameNuclear pore complex protein Nup88
TaxID9606
Evidenceevidence at protein level
Length741
SequenceStatuscomplete
DateCreated2002-11-08
DateModified2021-06-02

Ontological Relatives

GenesNUP88

GO terms

Show/Hide Table
GOName
GO:0000055 ribosomal large subunit export from nucleus
GO:0000056 ribosomal small subunit export from nucleus
GO:0000278 mitotic cell cycle
GO:0005215 transporter activity
GO:0005643 nuclear pore
GO:0005654 nucleoplasm
GO:0005829 cytosol
GO:0006110 regulation of glycolytic process
GO:0006406 mRNA export from nucleus
GO:0006409 tRNA export from nucleus
GO:0006606 protein import into nucleus
GO:0016032 viral process
GO:0016925 protein sumoylation
GO:0017056 structural constituent of nuclear pore
GO:0019058 viral life cycle
GO:0019083 viral transcription
GO:0043657 host cell
GO:0060964 regulation of gene silencing by miRNA
GO:0075733 intracellular transport of virus
GO:1900034 regulation of cellular response to heat

Subcellular Location

Show/Hide Table
Subcellular Location
Nucleus

Domains

Show/Hide Table
DomainNameCategoryType
IPR019321 Nucleoporin Nup88FamilyFamily
IPR037700 Nucleoporin NUP88/NUP82FamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
618393 OMIMFetal akinesia deformation sequence 4 (FADS4)A clinically and genetically heterogeneous group of disorders with congenital malformations related to impaired fetal movement. Clinical features include fetal akinesia, intrauterine growth retardation, polyhydramnios, arthrogryposis, pulmonary hypoplasia, craniofacial abnormalities, and cryptorchidism. FADS4 inheritance is autosomal recessive. The disease is caused by variants affecting the gene represented in this entry. Disease mechanism likely includes impaired formation of the neuromuscular junction. NUP88 silencing in vitro results in reduced levels of rapsyn, a key player in clustering of nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction. Decreased rapsyn levels have also been observed in a patient muscle biopsy.